KORU Medical Systems, Inc. (KRMD) - Form 8-K Summary
Business Context and Reporting Period
KORU Medical Systems, Inc. filed this Current Report on Form 8-K on May 6, 2026, to announce financial results for the first fiscal quarter ended March 31, 2026. The Company also reiterated its financial guidance for the full fiscal year ending December 31, 2026. A conference call regarding these results was scheduled for May 6, 2026.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report references a press release (Exhibit 99.1) containing the detailed financial results and a reconciliation of GAAP to non-GAAP measures. The Company utilizes "adjusted EBITDA" and "adjusted diluted EPS" as supplemental non-GAAP measures to evaluate performance, excluding items such as depreciation, amortization, interest, litigation expenses, and stock-based compensation.
Material Changes
The filing does not contain specific data points to compare current period performance against prior periods. Investors are directed to the attached press release for detailed comparisons and trend analysis.
Guidance, Outlook, and Management Commentary
- Guidance: Management reiterated its financial guidance for the fiscal year 2026.
- Non-GAAP Measures: Management emphasizes the use of adjusted EBITDA and adjusted diluted EPS to provide a clearer view of ongoing operational results and cash flow generating capacity.
- Cautionary Note: The Company cautions that non-GAAP measures should not be considered replacements for GAAP measures and may differ from similar measures used by other companies.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 revenue, net income, and cash flow figures.
- Examine the reconciliation table in the press release to understand the adjustments made to derive adjusted EBITDA and adjusted diluted EPS.
- Verify the specific details of the reiterated full-year 2026 financial guidance.
- Check for any updates on litigation expenses mentioned as an adjustment item in the non-GAAP definitions.